AtorvaStatin Postpartum and Reduction of Cardiovascular risK | MicrobiomeTrials← Back to trialsNCT06632379
AtorvaStatin Postpartum and Reduction of Cardiovascular risK
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2025-10-03Est. Completion: 2027-09-15
Enrollment target: 76 participants Locations- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus, Ohio, United States
Other microbiome trials you might be interested in
Hypertensive Disorder of PregnancyPreeclampsia
The purpose of this study is to compare latency (prolongation of pregnancy from diagnosis till delivery) in patients wit…
Columbus, United StatesEst. completion Dec 2027
Preeclampsia
The researchers are testing a medication named ravulizumab for the treatment of severe preeclampsia and Hemolysis, Eleva…
Rochester, United StatesEst. completion Dec 31, 2028